Prenylamine: Difference between revisions

Latest revision as of 03:38, 13 February 2025

Prenylamine[edit]

Prenylamine is a pharmaceutical drug that was primarily used as a calcium channel blocker and antianginal agent. It was developed in the mid-20th century and was used to treat angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart.

Mechanism of Action[edit]

Prenylamine functions by inhibiting the influx of calcium ions through calcium channels in the cardiac muscle and smooth muscle of the coronary arteries. This action leads to a decrease in myocardial oxygen demand and an increase in coronary blood flow, thereby alleviating the symptoms of angina.

Pharmacokinetics[edit]

Prenylamine is administered orally and is absorbed through the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, which affects its bioavailability. The drug is metabolized into several active and inactive metabolites, which are excreted primarily through the urinary system.

Clinical Use[edit]

Prenylamine was used in the management of chronic stable angina. It was considered effective in reducing the frequency and severity of anginal attacks. However, due to the development of newer and safer antianginal medications, the use of prenylamine has declined.

Side Effects[edit]

Common side effects of prenylamine included dizziness, nausea, and fatigue. More serious adverse effects involved cardiac arrhythmias and hypotension. Due to these potential risks, its use was carefully monitored.

Withdrawal from Market[edit]

Prenylamine was eventually withdrawn from the market in many countries due to concerns over its safety profile, particularly the risk of inducing torsades de pointes, a type of life-threatening arrhythmia.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-'''Prenylamine''' is a [[vasodilator]] that was introduced in the 1960s for the treatment of [[angina pectoris]], a condition characterized by chest pain or discomfort due to [[coronary heart disease]]. It functions by increasing blood flow to the heart muscle, thereby relieving symptoms associated with reduced blood supply. Prenylamine is classified as a calcium channel blocker, although its exact mechanism of action differs slightly from other drugs in this category. It is known to block calcium influx into cells and also has some [[beta blocker]] properties, although these are not its primary mode of action.
+== Prenylamine ==
-==Mechanism of Action==
+[[File:Prenylamine.svg|thumb|right|Chemical structure of Prenylamine]]
-Prenylamine works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells through voltage-dependent [[calcium channels]]. This inhibition leads to vasodilation, or the widening of blood vessels, which in turn reduces the workload on the heart and increases oxygen supply to the heart muscle. The drug's unique action also involves modulating the release of [[norepinephrine]], a neurotransmitter involved in the body's fight or flight response, which can further contribute to its vasodilatory effects.
-==Indications==
+'''Prenylamine''' is a pharmaceutical drug that was primarily used as a [[calcium channel blocker]] and [[antianginal agent]]. It was developed in the mid-20th century and was used to treat [[angina pectoris]], a condition characterized by chest pain due to reduced blood flow to the heart.
-Originally, prenylamine was used in the management of angina pectoris due to its ability to improve blood flow to the heart muscle. It was prescribed to patients who experienced chest pain as a result of their heart not receiving enough oxygen. However, its use has significantly declined due to the discovery of serious side effects.
-==Side Effects and Safety==
+=== Mechanism of Action ===
-The use of prenylamine has been associated with significant side effects, including the potential for [[QT interval]] prolongation and serious ventricular arrhythmias, such as [[torsades de pointes]]. These cardiac side effects have led to a reevaluation of the drug's safety profile and have resulted in its withdrawal from the market in many countries. Additionally, prenylamine may cause other less severe side effects such as nausea, dizziness, and headache.
+Prenylamine functions by inhibiting the influx of calcium ions through [[calcium channels]] in the [[cardiac muscle]] and [[smooth muscle]] of the [[coronary arteries]]. This action leads to a decrease in [[myocardial oxygen demand]] and an increase in [[coronary blood flow]], thereby alleviating the symptoms of angina.
-==Withdrawal from Market==
+=== Pharmacokinetics ===
-Due to its adverse effects on the heart, prenylamine was withdrawn from the market in several countries during the late 20th century. The risk of life-threatening arrhythmias, particularly in patients with pre-existing heart conditions, outweighed the benefits of its use in treating angina pectoris.
+Prenylamine is administered orally and is absorbed through the [[gastrointestinal tract]]. It undergoes extensive [[first-pass metabolism]] in the [[liver]], which affects its [[bioavailability]]. The drug is metabolized into several active and inactive metabolites, which are excreted primarily through the [[urinary system]].
-==Current Status==
+=== Clinical Use ===
-As of the last update, prenylamine is no longer widely used or available for the treatment of angina or any other condition. Its history serves as an example of the importance of rigorous drug safety and efficacy evaluation processes. Research into safer and more effective treatments for angina and other cardiovascular diseases continues, with the aim of improving patient outcomes while minimizing risks.
+Prenylamine was used in the management of chronic stable angina. It was considered effective in reducing the frequency and severity of anginal attacks. However, due to the development of newer and safer antianginal medications, the use of prenylamine has declined.
-==See Also==
+=== Side Effects ===
+Common side effects of prenylamine included [[dizziness]], [[nausea]], and [[fatigue]]. More serious adverse effects involved [[cardiac arrhythmias]] and [[hypotension]]. Due to these potential risks, its use was carefully monitored.
+=== Withdrawal from Market ===
+Prenylamine was eventually withdrawn from the market in many countries due to concerns over its safety profile, particularly the risk of inducing [[torsades de pointes]], a type of life-threatening arrhythmia.
+== Related Pages ==
 * [[Calcium channel blocker]]
 * [[Angina pectoris]]
-* [[Vasodilator]]
+* [[Cardiac arrhythmia]]
-* [[Beta blocker]]
+* [[Coronary artery disease]]
-* [[QT interval]]
-* [[Torsades de pointes]]
-[[Category:Vasodilators]]
 [[Category:Calcium channel blockers]]
+[[Category:Antianginal agents]]
 [[Category:Withdrawn drugs]]
-{{medicine-stub}}